We are live on
!
Find out more
CRB
Chad R. Baker Portfolio holdings
AUM
$620M
1-Year Est. Return
42.67%
This Fund
S&P 500
This Quarter
Est. Return
+1.86%
1 Year Est. Return
+42.67%
3 Year Est. Return
+108.31%
5 Year Est. Return
+132.07%
10 Year Est. Return
+563.15%
AUM
$226M
AUM Growth
-$6.22M
(-2.7%)
Cap. Flow
-$8.11M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
39.35%
Holding
60
New
1
Increased
–
Reduced
20
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adient
ADNT
|
+$600K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$4.74M |
| 2 |
STKL
SunOpta
STKL
|
+$3.01M |
| 3 |
Johnson & Johnson
JNJ
|
+$337K |
| 4 |
Mastercard
MA
|
+$49.2K |
| 5 |
Target
TGT
|
+$48.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.52% |
| 2 | Industrials | 24.75% |
| 3 | Consumer Staples | 13.96% |
| 4 | Technology | 13.36% |
| 5 | Communication Services | 8.84% |
Similar funds
PLU
RR
TAIM
KGAMU
GPWA
MAC
BT
IC
Chad R. Baker's Q4 2016 Portfolio in Review
As of Q4 2016, Chad R. Baker held 60 positions worth $226M, down 2.7% from $233M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Chad R. Baker withdrew a net $8.11M in Q4 2016, closing 1 position and reducing 20 holdings. Its most notable exit was SunOpta, an estimated $3.01M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Staples.
Against the trend, Chad R. Baker opened a new position in Adient worth $665K.
- Chad R. Baker's largest Q4 2016 buy was Adient: 11,357 shares worth $665K.
- Chad R. Baker's biggest Q4 2016 reduction was Novartis, cutting an estimated $4.74M.
- Chad R. Baker fully exited SunOpta in Q4 2016, selling an estimated $3.01M.
- Chad R. Baker's ten largest holdings make up 39% of its $226M portfolio in Q4 2016.
- Chad R. Baker opened 1 new position and closed 1 in Q4 2016.
- Chad R. Baker's portfolio value fell 2.7% quarter-over-quarter to $226M.
Based on Chad R. Baker's 13F filing for Q4 2016, filed 3 Feb 2017.